Drug · DIN 02459574
AFSTYLA
ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT), SINGLE CHAIN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since September 27, 2024.
- Drug Identification Number (DIN)
- 02459574
- Company (DIN owner)
- Csl Behring Canada IncOttawa, Ontario, Canada
- Schedule
- Schedule d
- Dosage form
- Kit; Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Coagulation factor viii B02BD02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LONOCTOCOG ALFA | 1500 UNIT | VIAL |
Other DINs named AFSTYLA
- DIN 02459531 · Cancelled Pre Market
- DIN 02459558 · Cancelled Pre Market
- DIN 02459566 · Cancelled Pre Market
- DIN 02459582 · Cancelled Pre Market
- DIN 02459590 · Cancelled Pre Market
- DIN 02459604 · Cancelled Pre Market